PGEN Competitors & Alternatives
Compare Precigen Inc with similar stocks in the same industry
Biotechnology
PGEN
Main Stock$4.66
Tradestie Score
65
Market Cap
$1.18B
P/E Ratio
42.9
Revenue Growth
24.4%
Analyst Upside
+200.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.48
|
$1.81B | - | 48 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.62
|
$1.78B | - | 57 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.01
|
$1.78B | - | 49 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$114.22
|
$1.77B | - | 53 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.48
|
$1.74B | - | 42 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.53
|
$1.68B | - | 49 | Compare |
|
MNKD
Mannkind Corporation
|
$4.16
|
$1.65B | - | 32 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$45.82
|
$1.63B | 5.7 | 37 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.07
|
$1.57B | - | 41 | Compare |
|
VCEL
Vericel Corporation
|
$57.42
|
$1.56B | 92.9 | 32 | Compare |
More PGEN Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry